Detalhe da pesquisa
1.
The mortality risk factor of community acquired pneumonia patients with chronic obstructive pulmonary disease: a retrospective cohort study.
BMC Pulm Med
; 18(1): 12, 2018 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29357862
2.
Albumin-Based LL37 Peptide Nanoparticles as a Sustained Release System against Pseudomonas aeruginosa Lung Infection.
ACS Biomater Sci Eng
; 7(5): 1817-1826, 2021 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33966375
3.
PM2.5 compromises antiviral immunity in influenza infection by inhibiting activation of NLRP3 inflammasome and expression of interferon-ß.
Mol Immunol
; 125: 178-186, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32717666
4.
LL37 Inhibits Aspergillus fumigatus Infection via Directly Binding to the Fungus and Preventing Excessive Inflammation.
Front Immunol
; 10: 283, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30842778
5.
Viral infection in community acquired pneumonia patients with fever: a prospective observational study.
J Thorac Dis
; 10(7): 4387-4395, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30174887